FDA experts vote to yank the agency’s 2011 OK of controversial preterm birth drug after a trial failure

FDA experts vote to yank the agency’s 2011 OK of controversial preterm birth drug after a trial failure  Endpoints News

Read More »

Leave a Reply

Your email address will not be published. Required fields are marked *